Atlas Venture Fund X L.P. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-06 5:00 pm Sale | 2022-11-23 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 1,498,635 3.000% | -665,402 (-30.75%) | Filing |
| 2022-09-14 5:06 pm Sale | 2022-09-12 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,164,037 4.400% | -360,829 (-14.29%) | Filing |
| 2020-09-17 4:50 pm Sale | 2020-09-15 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,524,866 6.300% | -436,607 (-14.74%) | Filing |
| 2020-07-07 5:11 pm Sale | 2020-07-02 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,961,473 7.500% | -436,607 (-12.85%) | Filing |
| 2020-06-19 5:03 pm Sale | 2020-06-16 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 3,398,080 8.600% | -436,507 (-11.38%) | Filing |